Table 4 – Secondary outcomes
From: Analysis of antibiotic use and clinical outcomes in adults with known and suspected pleural empyema
Survived after 90 days (n = 318) | Died within 90 days (n = 11) | p-value | Not readmitted within 30 days (n = 290) | Readmitted within 30 days (n = 49) | p-value | Not readmitted for empyema within 30 days (n = 321) | Readmitted for empyema within 30 days (n = 17) | p-value | |
|---|---|---|---|---|---|---|---|---|---|
Total antibiotic duration (days) | 16 (11–28) | 16 (8–24) | 0.270 | 17 (11–28) | 14 (9–21) | 0.018 | 17 (11–28) | 13 (6–15) | 0.010 |
IV antibiotic duration (days) | 7 (4–16) | 10 (4–24) | 0.669 | 7 (4–16) | 9 (5–18) | 0.603 | 7 (4–16) | 8 ( 3–15) | 0.391 |
Anti-anaerobic antibiotic duration (days) | 7 (0–16) | 3 (1–10) | 0.520 | 8.5 (0–17) | 2 (0–11) | 0.003 | 8 (0–17) | 2 (0–3) | 0.003 |